Connect with us

Technology

MGI Tech announces partnership with Universidad de San Martín de Porres to strengthen human genetics research

Published

on

The implementation of MGI Tech’s next-generation genomic sequencing (NGS) technologies will strengthen scientific research in the country, enabling the identification of key genetic variations, contributing to disease prevention, and personalizing medical treatments.A team of specialists from USMP will work on advancing five research projects focused on rare diseases, infectious diseases, cancer, pharmacogenomics as well as understanding the genetics of native communities.

LIMA, Peru, Dec. 1, 2024 /PRNewswire/ — MGI Tech Co., Ltd. (“MGI”), a company committed to building core tools and technologies that drive innovation in life science, announced a partnership with the Universidad de San Martín de Porres to strengthen human genetics research through the implementation of next-generation genomic sequencing (NGS) technologies in the laboratory in the laboratory of the university’s Genetic and Molecular Biology Research Center. This advancement will enable the identification of genetic risk factors in the population for the development of future public health treatments.

Carlos Carpio, Commercial Director for MGI Latin America, highlights that this partnership is a milestone will significantly enhance genetic research in the country by enabling large-scale studies of human genomes, exomes, and metagenomics with more speed and precision in Peru and Andean countries. “This technological upgrade will allow for the complete automation of the process, from sample preparation to bioinformatic analysis. The implementation will not only reduce research times and costs but also democratize access to this technology in the country, providing more opportunities for training highly specialized professionals in genomics and bioinformatics.”

The laboratory is equipped with the DNBSEQ-G400RS sequencer*, the MGISP-100 automated library preparation system, and MGI’s MEGABOLT bioinformatics accelerator, which will enable USMP researchers to carry out advanced studies with precision and speed.

Dr. Ricardo Fujita, Director of the Research Institute and investigator of the Genetic and Molecular Biology Research Center of the Faculty of Human Medicine at the Universidad de San Martín de Porres, points out that Peruvians and Andean populations are part of the 80% of global populations that are not represented in medical and genomic studies.

“The lack of inclusion limits the ability to identify the genetic causes of various conditions such as rare diseases, cancer, or diabetes, or responding adequately to drugs, making it difficult to treat them in a personalized and effective way.”

A recent study by the Universidad de San Martín de Porres reveals that the average indigenous genetic heritage of the Peruvian population is 70%, underscoring the need to investigate specific genetic characteristics for the study of diseases and the development of more precise treatments.

Thanks to this advanced technology, Dr. Fujita, along with seven researchers from the university, will lead five ambitious research projects:

Rare diseases: Focusing on neurological, neuromuscular, ocular, dermatological, autism spectrum, and developmental conditions.Cancer: Over the next two years, they will analyze 200 cases of sporadic cancers (without family history or hereditary mutations) to study hereditary predispositions and explore genetic and epigenetic markers.Immunogenomics and pharmacogenomics: Genetic variants in the Peruvian population that influence susceptibility and resistance to infections will be investigated.Genetics of native populations: In four years, 1,000 genomes from South American native populations will be contributed to open databases, helping build a Peruvian BioBank.Metagenomics: 1,000 metagenomic samples will be analyzed to study microorganisms causing infectious diseases, especially transmissible ones, and the normal human microbiome in the Andes and Peruvian Amazon over the next two years.

Dr. Fujita highlights that, with the implementation of this technology, the university will be able to collaborate closely with hospitals and academic institutions in researching diseases prevalent in Peru and neighboring countries. “The incorporation of MGI Tech’s state-of-the-art equipment will promote a significant advance in genetic research in the region. This will make it possible to identify genetic risk factors specific to our population and contribute to the development of personalized treatments tailored to local needs.”

Furthermore, the expert predicts that this technology will strengthen the training of future professionals in genetic medicine and molecular biology. “This initiative positions USMP as a leader in genomic research in the region, driving the development of personalized medicine and contributing to a better understanding of human health.”

*For Research use only and not for use in any diagnostic procedures.

About MGI 

MGI Tech Co., Ltd. (or its subsidiaries, together referred to MGI) is committed to building core tools and technologies that drive innovation in life science. Our focus lies in research & development, manufacturing, and sales of instruments, reagents, and related products in the field of life science and biotechnology. We provide real-time, multi-omics, and full spectrum of digital equipment and systems for precision medicine, agriculture, healthcare and various other industries. 

Founded in 2016, MGI has grown into a leader in life science, serving customers across six continents and have established research, manufacturing, training, and after-sales service facilities globally. MGI stands out as one of the few companies capable of independently developing and mass-producing clinical-grade gene sequencers with varying throughput capacities, ranging from Gb to Tb levels. With unparalleled expertise, cutting-edge products, and a commitment to global impact, MGI continues to shape the trajectory of life sciences into the future. To learn more, please visit https://en.mgi-tech.com/, LinkedIn, X, and YouTube

View original content to download multimedia:https://www.prnewswire.com/news-releases/mgi-tech-announces-partnership-with-universidad-de-san-martin-de-porres-to-strengthen-human-genetics-research-302319332.html

SOURCE MGI TECH

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Vivalink Recognized with 2024 Global Healthcare IT Solutions Award by Frost & Sullivan

Published

on

By

Vivalink honored for enabling technology leadership with its innovative remote patient monitoring solutions

CAMPBELL, Calif., Jan. 9, 2025 /PRNewswire/ — Vivalink, a leading provider of digital healthcare solutions, receives Frost & Sullivan’s 2024 Global Healthcare IT Solutions Enabling Technology Leadership Award. This distinction highlights Vivalink as a leader in the global remote patient monitoring (RPM) market for worldwide clinical applications of hospital-at-home, cardiac monitoring and clinical trials.

Frost & Sullivan’s Enabling Technology Leadership Award recognizes companies that apply their technology in new ways to improve existing products and services and elevate the customer experience. Its primary criteria includes Vivalink’s leveraging of technology to improve efficiency, application diversity and creativity, as well as its customer impact through performance, customer experience and brand equity.

Vivalink’s medical-grade wearable technology enables providers to deliver patient-centered care for hospital-at-home services, ambulatory cardiac monitoring, and remote clinical trials. Unlike traditional RPM systems, Vivalink offers continuous, real-time monitoring for a variety of specialties, including cardiology, oncology and neurology, while supporting chronic condition management, early interventions, and specialized applications.

“Frost & Sullivan commends Vivalink for its strategic focus on addressing critical unmet needs and limitations within traditional remote patient monitoring systems, thus accelerating its leadership in the increasingly competitive space,” said Dr. Rishi Pathak, research director at Frost & Sullivan. “With its flexible, versatile, and scalable Biometrics Data Platform and unique business model, the company strategically positions its platform as a convenient, cost-effective, and advanced solution, helping Vivalink capture significant market share.”

This award highlights Vivalink’s commitment to innovation, creativity, and ability to launch new solutions with far-reaching impact and application. Through its evolving solutions, Vivlink enables the integration of RPM technologies for modern healthcare delivery and optimized patient care.

“It is an honor to be recognized as a global leader of health IT solutions, highlighting our commitment to providing informed, continuous data that drives modern healthcare delivery models,” said Jiang Li, PhD and CEO of Vivalink.

For a copy of the detailed award write-up, see: www.vivalink.com/HealthIT_Award

About Vivalink
Vivalink is a provider of digital healthcare solutions for remote patient monitoring in healthcare and clinical trials. By combining medical wearables, advanced algorithms, and clinical applications, we provide a more effective and accessible approach to patient care worldwide.

About Frost & Sullivan
Frost & Sullivan is the Growth Pipeline Company™. We power our clients to a future shaped by growth. Our Growth Pipeline as a ServiceTM provides the CEO and the CEO’s growth team with a continuous and rigorous platform of growth opportunities, ensuring long-term success. To achieve positive outcomes, our team leverages over 60 years of experience, coaching organizations of all types and sizes across 6 continents with our proven best practices. To power your Growth Pipeline future, visit Frost & Sullivan at http://www.frost.com.

Media Contact:
pr@vivalink.com

View original content:https://www.prnewswire.com/news-releases/vivalink-recognized-with-2024-global-healthcare-it-solutions-award-by-frost–sullivan-302347191.html

SOURCE Vivalink

Continue Reading

Technology

IDEMIA Awarded 10-Year Blanket Purchase Agreement from the General Services Administration for Next-Generation Identity Proofing for Login.Gov

Published

on

By

IDEMIA offers trusted identity proofing and verification platforms backed by decades-long history of partnership with government agencies.

RESTON, Va., Jan. 9, 2025 /PRNewswire/ — IDEMIA Public Security North America, a leader in identity security and authentication services, has been awarded a 10-year blanket purchase agreement (BPA) worth up to $194.5 million from the General Services Administration (GSA) for its identity proofing capabilities. IDEMIA is one of 8 technology providers selected by GSA to accelerate the deployment of next-generation identity proofing technologies for Login.gov, a secure sign-in platform used by the public to create a single digital account that can be used to access multiple federal, state and local government agency sites.

After a rigorous qualification process by GSA, IDEMIA was selected for its robust and trusted identity proofing and verification technology, designed to ensure that individuals are who they say they are and prevent identity-related fraud, and its long-standing history of more than 60 years serving government agencies. IDEMIA’s Identity and Verification (ID&V) solution incorporates document authentication technology with comprehensive checks, such as digital tampering detection, document identification, font anomaly detection, liveness detection, and face capture. It complies with the highest security standards and is certified by the Kantara Initiative as compliant with NIST SP 800-63 rev. 3 Component Service at Identity Assurance Level 2 (IAL2).

IDEMIA’s identity proofing technology supports both active and passive facial liveness detection during authentication to ensure the person behind the camera is an actual individual. This technology has been awarded Level 1 and Level 2 compliance by iBeta in accordance with the ISO/IEC 30107-3 standards and most recently the Department of Homeland Security Science and Technology Department (DHS S&T). In addition, IDEMIA has incorporated accessibility and usability design feedback from Applause, a world leader in testing and digital quality, to ensure that IDEMIA’s identity proofing technology conforms with Web Content Accessibility Guidelines (WCAG).

“We look forward to serving GSA as a committed technology partner, supporting their digital transformation efforts to improve identity verification and customer experience of Login.gov, which is accessed by millions of users,” shared Donnie Scott, CEO, IDEMIA Public Security North America.

IDEMIA’s ID&V solutions are trusted by public and private organizations across the globe. It serves as the backbone of IDEMIA’s Mobile ID issuance technology, which has been rolled out in New York, Arizona, Delaware, Iowa, and Mississippi, with more states to launch in the coming months.

To learn more about IDEMIA’s Identity and Verification solutions, click here.

About IDEMIA Public Security North America
IDEMIA Public Security North America is a leader in identity security and authentication services to governments and private companies operating in North America. Our mission is to Unlock the World, Make It Safer – helping people access what matters most, more quickly, more safely, and more securely, in both the physical and the digital worlds. Our best-in-class technology helps to authenticate and secure physical and digital transactions. IDEMIA is recognized by the National Institute of Standards (NIST) as a top-ranking participant in the Institute’s passenger facilitation simulation testing as well as in its regular Biometrics Technology Evaluations rankings, reinforcing the trustworthiness and reliability of IDEMIA’s facial recognition solutions for government and consumers alike.  

Learn more at www.na.idemia.com / Follow @Idemia_NA on Twitter and on LinkedIn.

Media contact:  
Genevieve de Vera
IDEMIA Public Security North America
(978) 808-7047
genevieve.devera@us.idemia.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/idemia-awarded-10-year-blanket-purchase-agreement-from-the-general-services-administration-for-next-generation-identity-proofing-for-logingov-302347160.html

SOURCE IDEMIA Identity & Security USA LLC

Continue Reading

Technology

Topaz Labs to Expand Addison, TX Headquarters from 7,000 to 27,000 Square Feet; Add 130 High-Tech Jobs

Published

on

By

The Town of Addison secures Topaz Labs with a $200,000 grant to build amenities and collaborative spaces for a new office.

ADDISON, Texas, Jan. 9, 2025 /PRNewswire-PRWeb/ — Topaz Labs, the leading provider of AI-powered photo and video enhancement technology, and the Town of Addison announce an award of a $200,000 Amenities and Collaboration Grant to Topaz Labs to support the expansion of its headquarters, nearly tripling its current size.

” Topaz Labs is exactly the kind of company we love to see grow here in Addison,” said Wayne Emerson, Director of Economic Development at the Town of Addison. Their innovative work in AI and commitment to the Town make them the perfect partner.

The company will lease 28,208 square feet of office space — up from their current 7,000 square feet and expects to invest at least $2.5 million to customize the space with innovation labs and collaborative workspaces for staff. Topaz Labs will become the sole office tenant at Building 900, the newest building in Village on the Parkway, a vibrant mixed-use destination offering premier shopping, dining, and entertainment experiences.

As AI continues to be a booming industry nationally and locally in DFW, Topaz Labs expects to add 130 high-tech jobs by the end of 2027, further contributing to Addison’s reputation as a hub for innovation and technology.

” Topaz Labs is exactly the kind of company we love to see grow here in Addison,” said Wayne Emerson, Director of Economic Development at the Town of Addison. Their innovative work in AI and commitment to the Town make them the perfect partner. We’re also thrilled for their employees, who will enjoy working in a brand-new, highly amenitized building surrounded by great restaurants, entertainment options, and walkable amenities at Village on the Parkway.”

” We’re so excited for the future of Topaz Labs in Addison,” said Eric Yang, CEO at Topaz Labs. “We sought a vibrant, safe, and energetic community with like-minded professionals doing their best work. We’ve found all of that in Addison.”

” This transformative lease aligns seamlessly with Topaz Labs’ rapid growth in the AI industry, as well as our partnership with the Town of Addison. We are honored to have represented them in securing this exceptional space for their headquarters,’ said Nick Lee, President – Office Division and Principal at NAI.

Topaz Labs will begin occupying its new office space in May of 2025.

About Addison

Addison, Texas, is the Address for Success—a vibrant 4.4-square-mile urban hub offering over 200 restaurants, 22 hotels, 12 million square feet of office space, and upscale residential options. Home to Addison Airport, one of the busiest general aviation airports in Texas, and providing prime access to a diverse and highly skilled workforce, Addison is a strategic location for businesses to thrive. Addison is a premier destination in North Texas, known for its world-class special events and exceptional amenities. Learn more at http://www.addisoned.com/

About Topaz Labs

Topaz Labs is the innovator in AI image and video enhancement software for enterprise-scale and professional videographers, cinematographers, post-production specialists, and consumer photographers alike to improve images and video at a speed and scale never before seen. Topaz Labs allows users to upscale, sharpen, and remove noise from blurry or otherwise imperfect images and videos. The company has 1.5 million customers worldwide. For more information, please visit www.topazlabs.com.

About NAI

NAI Robert Lynn, established in 1962, is a leading commercial real estate firm specializing in Dallas/Fort Worth. With a comprehensive range of services—including office, retail, industrial, property management, capital markets, corporate services, site selection, land, and consulting— the firm combines local expertise with global reach to deliver tailored solutions for clients. Their deep-rooted presence and proactive market approach have solidified their reputation as industry leaders. For more information, please visit www.nairl.com.

Media Contact

Wayne Emerson, Town of Addison, 1 9724507076, wemerson@addisontx.gov, addisoned.com

View original content:https://www.prweb.com/releases/topaz-labs-to-expand-addison-tx-headquarters-from-7-000-to-27-000-square-feet-add-130-high-tech-jobs-302346695.html

SOURCE Town of Addison

Continue Reading

Trending